Login / Signup

Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR + breast cancer and negative axillary ultrasound.

Aubriana M McEvoySteven PoplackKatelin NickelMargaret A OlsenFoluso AdemuyiwaImran ZoberiElizabeth OdomJennifer YuSu-Hsin ChangWilliam E Gillanders
Published in: Breast cancer research and treatment (2020)
Considering both cost and effectiveness, observation is superior to SLNB in postmenopausal women with cT1-T2 N0, HR+/HER2- breast cancer and negative AUS.
Keyphrases